DOvEE - Diagnosing Ovarian & Endometrial Cancer Early

Official Title

Diagnosing Ovarian & Endometrial Cancer Early (DOvEE) by Targeting Symptomatic Women


This study hopes to improve early detection of ovarian and endometrial cancers. It will determine if women with bloating, abdominal distension, abdominal/pelvic pain, increased urinary frequency and/or early satiety, benefit from earlier surgery after screening by CA-125 ovarian cancer biomarker and transvaginal ultrasound.

Trial Description

Primary Outcome:

  • Proportion of diagnoses in early, curable stage.
Secondary Outcome:
  • Number of participants with physical morbidity related to the program as a measure of safety and tolerability

View this trial on

Interested in this trial?

Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.


Canadian Cancer Society

These resources are provided in partnership with the Canadian Cancer Society